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background:  Current guidelines more clearly favor cardiac resynchronization defibrillator therapy (CRT-D) for low ejection fraction (EF) 
heart failure patients with left bundle branch block (LBBB) >150ms over those with right ventricular pacing (RVP). The aim was to evaluate 
ventricular arrhythmias after CRT by baseline QRS width and morphology vs. RVP.
Methods:  We studied 296 consecutive CRT-D patients with QRS ≥120ms, NYHA class II-IV and EF ≤35%. RVP was defined as those 
with pacing ≥40% of the time before CRT-D. Outcome events were pre-defined as death, appropriate anti tachycardia pacing (ATP) or 
appropriate shock within 2 years.
results:  Of 296 CRT patients, 61% had ischemic disease, 65±11 years, QRS 159±2ms and baseline LVEF 24±6%. There were 102 (34%) 
with LBBB >150ms, 157 (53%) with LBBB and QRS 120-150ms or non-LBBB (intermediate group), and 37 (13%) were RVP. Overall, there 
were 49 ventricular arrhythmic events (25 ATP and 24 shocks) in 2 years: 11% in LBBB with QRS >150ms, 22% in the intermediate QRS 
group, and 11% in RVP patients. In a multivariate analysis, RVP had a similar arrhythmia risk after CRT as LBBB QRS >150ms and a lower 
arrhythmia risk than intermediate QRS group: adjusted hazard ratio 0.28 (95% CI 0.09 to 0.89, p=0.03).
Conclusion:  The risk of serious ventricular arrhythmias after CRT-D in RVP patients was similar to patients with baseline wide LBBB and 
QRS >150ms and significantly better than LBBB 120-149ms and non-LBBB patients. These data further support benefits of CRT-D for RVP 
patients.
 
